Linmar Guilarte-Rodriguez

Santiago, RM, Chile

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Regulation of antiviral immunity by PD-1 during respiratory syncitial virus infection and upon vaccination.

Regulation of antiviral immunity by PD-1 during respiratory syncitial virus infection and upon vaccination.

Journal: iScience

Published: October 16, 2025

Human respiratory syncytial virus causes maternal inflammation in pregnant mice and behavioral alterations in the offspring.

Human respiratory syncytial virus causes maternal inflammation in pregnant mice and behavioral alterations in the offspring.

Journal: Brain, behavior, and immunity

Published: September 05, 2025

A booster dose of an inactivated SARS-CoV-2 vaccine targeting virus variants sustains protective humoral and cellular immunity.

A booster dose of an inactivated SARS-CoV-2 vaccine targeting virus variants sustains protective humoral and cellular immunity.

Journal: BMC medicine

Published: April 23, 2025

Preclinical characterisation of the protective capacity of an anti-nucleoprotein hRSV monoclonal antibody.

Preclinical characterisation of the protective capacity of an anti-nucleoprotein hRSV monoclonal antibody.

Journal: EBioMedicine

Published: April 10, 2025

Age and primary vaccination schedule impact humoral and cellular immunity with an inactivated SARS-CoV-2 vaccine.

Age and primary vaccination schedule impact humoral and cellular immunity with an inactivated SARS-CoV-2 vaccine.

Journal: iScience

Published: February 14, 2025

T Cell Response Evaluation After A Fifth Dose of an Inactivated SARS-CoV-2 Vaccine Using Multiparametric Flow Cytometry.

T Cell Response Evaluation After A Fifth Dose of an Inactivated SARS-CoV-2 Vaccine Using Multiparametric Flow Cytometry.

Journal: European journal of immunology

Published: January 31, 2025

Influenza vaccines promote humoral and cellular immune responses: a randomized, double-blind, phase 3 trial.

Influenza vaccines promote humoral and cellular immune responses: a randomized, double-blind, phase 3 trial.

Journal: Nature communications

Published: January 27, 2025

Immunomodulatory markers and therapies for the management of infant respiratory syncytial virus infection.

Immunomodulatory markers and therapies for the management of infant respiratory syncytial virus infection.

Journal: Expert review of anti-infective therapy

Published: September 13, 2024

Pathophysiological, immunological, and inflammatory features of long COVID.

Pathophysiological, immunological, and inflammatory features of long COVID.

Journal: Frontiers in immunology

Published: November 20, 2023

Contribution of viral and bacterial infections to senescence and immunosenescence.

Contribution of viral and bacterial infections to senescence and immunosenescence.

Journal: Frontiers in cellular and infection microbiology

Published: May 25, 2023

Characterization of the humoral and cellular immunity induced by a recombinant BCG vaccine for the respiratory syncytial virus in healthy adults.

Characterization of the humoral and cellular immunity induced by a recombinant BCG vaccine for the respiratory syncytial virus in healthy adults.

Journal: Frontiers in immunology

Published: May 02, 2023

LAG-3 Contribution to T Cell Downmodulation during Acute Respiratory Viral Infections.

LAG-3 Contribution to T Cell Downmodulation during Acute Respiratory Viral Infections.

Journal: Viruses

Published: October 11, 2022

Showing 1-12 of 14

Last Updated: 09/26/2026